Related Experiment Video
Updated: Aug 19, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Mathematical modeling of the regulation of caspase-3 activation and degradation
Jörg W Stucki1, Hans-Uwe Simon
1Department of Pharmacology, University of Bern, Friedbühlstrasse 49, CH-3010 Bern, Switzerland. joerg.stucki@pki.unibe.ch
Abstract:
Caspases are thought to be important players in the execution process of apoptosis. Inhibitors of apoptosis (IAPs) are able to block caspases and therefore apoptosis. The fact that a subgroup of the IAP family inhibits active caspases implies that not each caspase activation necessarily leads to apoptosis. In such a scenario, however, processed and enzymically active caspases should somehow be removed. Indeed, IAP-caspase complexes covalently bind ubiquitin, resulting in degradation by the 26S proteasome. Following release from mitochondria, IAP antagonists (e.g. second mitochondrial activator of caspases (Smac)) inactivate IAPs. Moreover, although pro-apoptotic factors such as irradiation or anti-cancer drugs may release Smac from mitochondria in tumor cells, high cytoplasmic survivin and ML-IAP levels might be able to neutralize it and, consequently, IAPs would further be able to bind activated caspases. Here, we propose a simple mathematical model, describing the molecular interactions between Smac deactivators, Smac, IAPs, and caspase-3, including the requirements for both induction and prevention of apoptosis, respectively. In addition, we predict a novel mechanism of caspase-3 degradation that might be particularly relevant in long-living cells.
Insights
This study models how inhibitors of apoptosis (IAPs) and Smac regulate apoptosis. It predicts a novel caspase-3 degradation pathway important for long-living cells.
Area of Science:
- Cell Biology
- Biochemistry
- Mathematical Biology
Background:
- Caspases execute apoptosis, but inhibitors of apoptosis (IAPs) can block this process.
- IAPs bind active caspases, preventing apoptosis, and IAP-caspase complexes are degraded by the proteasome.
- IAP antagonists like Smac neutralize IAPs, but cellular IAP levels can override Smac's effects.
Purpose of the Study:
- To develop a mathematical model of molecular interactions governing apoptosis.
- To describe the roles of Smac deactivators, Smac, IAPs, and caspase-3 in apoptosis.
- To predict mechanisms for caspase-3 degradation and apoptosis regulation.
Main Methods:
- Mathematical modeling of molecular interactions.
- Analysis of regulatory pathways involving Smac, IAPs, and caspase-3.
- Simulation of conditions for apoptosis induction and prevention.
Main Results:
- The model describes interactions between Smac deactivators, Smac, IAPs, and caspase-3.
- It outlines requirements for both initiating and preventing apoptosis.
- A novel caspase-3 degradation mechanism is predicted, potentially relevant in long-living cells.
Conclusions:
- Cellular IAP levels can counteract Smac's pro-apoptotic effects.
- Mathematical modeling provides insights into apoptosis regulation.
- A new caspase-3 degradation pathway is proposed, impacting cell survival and apoptosis.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of the Unfolded Protein Response
Apoptosis

